Log In Sign up
The largest database of trusted experimental protocols

Cd107b alexa fluor 647

Manufactured by BioLegend
Visit Supplier

CD107b-Alexa Fluor 647 is a fluorochrome-conjugated antibody that binds to the CD107b (LAMP-2) surface antigen. CD107b is a lysosome-associated membrane protein that is expressed on the cell surface during degranulation. The Alexa Fluor 647 fluorescent dye is used to label the antibody, allowing for the detection and quantification of CD107b-expressing cells by flow cytometry.

Automatically generated - may contain errors

Lab products found in correlation

Live dead fixable yellow dead cell stain, by Thermo Fisher Scientific (2 mentions) Cd8a fitc, by BioLegend (2 mentions) Cd3 apc cyanine7, by BioLegend (2 mentions) Cd62l pe, by BioLegend (1 mentions) Cd25 pe cy5, by BioLegend (1 mentions) Cd4 percp cy5, by BioLegend (1 mentions) Foxp3 efluor450, by Thermo Fisher Scientific (1 mentions) Tnf α brilliant violet 421, by BioLegend (1 mentions) Il 2 brilliant violet 711, by BioLegend (1 mentions) Ifn brilliant violet 785, by BioLegend (1 mentions) Cd44 pe cyanine 7, by BioLegend (1 mentions) Il 10 apc, by BioLegend (1 mentions)

Close spelling variants of this product

Alexa Fluor 647 (65 citations) Alexa 647 (11 citations) CD107b (2 citations)

2 protocols using cd107b alexa fluor 647

1

Multi-parameter Immune Cell Profiling

Check if the same lab product or an alternative is used in the 5 most similar protocols
CD44‐Brilliant Violet 711 (BioLegend, Cat.# 103057, clone: IM7, 1:80), CD8a‐FITC (BioLegend, Cat.# 100706, clone: 53‐6.7, 1:50), CD62L‐PE (BioLegend, Cat.# 104407, clone: MEL‐14, 1:80), CX3CR1‐PE/Cyanine 7 (BioLegend, Cat.# 149015, clone: SA011F11, 1:1333), CD107b‐Alexa Fluor 647 (BioLegend, Cat.# 108512, clone: M3/84, 1:200), CD3‐APC/Cyanine7 (BioLegend, Cat.# 100222, clone: 17A2, 1:80), and LIVE/DEAD Fixable Yellow Dead Cell Stain (Thermo Fisher Scientific, Cat.# L34967, 1:7500).
Matos A.I., Peres C., Carreira B., Moura L.I., Acúrcio R.C., Vogel T., Wegener E., Ribeiro F., Afonso M.B., Santos F.M., Martínez‐Barriocanal Á., Arango D., Viana A.S., Góis P.M., Silva L.C., Rodrigues C.M., Graca L., Jordan R., Satchi‐Fainaro R, & Florindo H.F. (2023). Polyoxazoline‐Based Nanovaccine Synergizes with Tumor‐Associated Macrophage Targeting and Anti‐PD‐1 Immunotherapy against Solid Tumors. Advanced Science, 10(25), 2300299.
+ Open protocol
+ Expand
2

Multiparametric Flow Cytometry Profiling

Check if the same lab product or an alternative is used in the 5 most similar protocols
TNF‐α‐Brilliant Violet 421 (BioLegend, Cat.# 506328, clone: MP6‐XT22, 1:80), FOXP3‐eFluor 450 (eBioscience, Cat.# 48‐5773‐82, clone: FJK‐16s, 1:300), IL‐2‐Brilliant Violet 711 (BioLegend, Cat.# 503837, clone: JES6‐5H4, 1:40), IFN‐ɣ‐Brilliant Violet 785 (BioLegend, Cat.# 505838, clone: XMG1.2, 1:80), CD8a‐FITC (BioLegend, Cat.# 100706, clone: 53‐6.7, 1:50), CD4‐PerCP‐Cy5.5 (BioLegend, Cat.# 100434, clone: GK1.5, 1:80), CD25‐PE/Cy5 (BioLegend, Cat.# 102010, clone: PC61, 1:80), CD44‐PE/Cyanine7 (BioLegend, Cat.# 103029, clone: IM7, 1:80), IL‐10‐APC (BioLegend, Cat.# 505010, clone: JES5‐16E3, 1:80), CD107b‐Alexa Fluor 647 (BioLegend, Cat.# 108512, clone: M3/84, 1:200), CD3‐APC/Cyanine7 (BioLegend, Cat.# 100222, clone: 17A2, 1:80), and LIVE/DEAD Fixable Yellow Dead Cell Stain (Thermo Fisher Scientific, Cat.# L34967, 1:7500).
Matos A.I., Peres C., Carreira B., Moura L.I., Acúrcio R.C., Vogel T., Wegener E., Ribeiro F., Afonso M.B., Santos F.M., Martínez‐Barriocanal Á., Arango D., Viana A.S., Góis P.M., Silva L.C., Rodrigues C.M., Graca L., Jordan R., Satchi‐Fainaro R, & Florindo H.F. (2023). Polyoxazoline‐Based Nanovaccine Synergizes with Tumor‐Associated Macrophage Targeting and Anti‐PD‐1 Immunotherapy against Solid Tumors. Advanced Science, 10(25), 2300299.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!